Johnson & Johnson Innovation and Janssen Research & Development Launch World Without Disease QuickFire Challenge
Largest QuickFire competition to date will award up to $500,000 in a research grant and entrance to
Johnson & Johnson Innovation, JLABS, to promising transformational healthcare solution
Challenge launched at 2016 BIO International Convention during the Bionic Innovation Forum
SAN FRANCISCO, June 6, 2016 — Johnson & Johnson Innovation LLC and Janssen Research &
Development today announced the launch of the World Without Disease QuickFire challenge. The
competition is the largest and most ambitious QuickFire challenge to date, representing an ongoing
commitment to support life science innovators and the development of integrated, cross-sector solutions
to prevent, intercept and cure diseases. Johnson & Johnson Innovation will consider global applicants
with solutions across the pharmaceutical, medical device and consumer sectors. The competition seeks to
find entrepreneurs, researchers or startup companies who are advancing potentially game-changing, early
stage innovations that have the potential to cross traditional boundaries of the pharmaceutical, device or
consumer health sectors. The recipient will receive a research grant totaling up to USD 500,000 and
entrance to a Johnson & Johnson Innovation, JLABS (JLABS) community.
Read more in the attached PDF.